ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

Study: Partial Kidney Removal Leads to Greater Survival

March 29, 2013

In Brief: Wynder To Receive Distinguished Achievement Award From ASPO; Brown Heads council Of Deans

February 24, 1984

In Brief: While House Floats Healy’s Name For NIH Post; USC To Enhance Norris Center With NCI Grants

September 14, 1990

Clearinghouse Subgroup asks For Tests On Three Chemicals

October 7, 1977

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004

DCCP Board Okays Concept Of Study On Black/White Survival Differences

March 5, 1982